Bright sparks in the biomedical sector

Singapore-based biotechnology firm Tessa Therapeutics (Tessa) has come a long way from the Singapore cafe where the idea of its inception was hatched.

Born over a discussion eight years ago between an immunologist and an oncologist, it is today ahead in the race to turn cancer patients' own immune cells (T-cells) against the tumours in their bodies.

Please or to continue reading the full article.

Get unlimited access to all stories at $0.99/month

  • Latest headlines and exclusive stories
  • In-depth analyses and award-winning multimedia content
  • Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*

*Terms and conditions apply.

A version of this article appeared in the print edition of The Sunday Times on March 04, 2018, with the headline 'Bright sparks'. Subscribe